Hood River Capital Management LLC Neurocrine Biosciences Inc Transaction History

Hood River Capital Management LLC

$5.79 Billion
Q4 2024

A detailed history of Hood River Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Hood River Capital Management LLC holds 355,058 shares of NBIX stock, worth $39.4 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

355,058

Previous 263,210 34.9%

Holding current value

$39.4 Million

Previous $30.3 Million 59.93%

% of portfolio

0.84%

Previous 0.56%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $10.3 Million - $12.8 Million	91,848 Added 34.9%	355,058 $48.5 Million
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $2.21 Million - $2.96 Million	19,313 Added 7.92%	263,210 $30.3 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $2.08 Million - $2.28 Million	15,899 Added 6.97%	243,897 $33.6 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $2.04 Million - $2.24 Million	15,608 Added 7.35%	227,998 $31.4 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $115,934 - $145,106	1,093 Added 0.52%	212,390 $28 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $168,577 - $209,960	-1,793 Reduced 0.84%	211,297 $23.8 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $630,828 - $738,914	7,046 Added 3.42%	213,090 $20.1 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $598,163 - $781,915	6,356 Added 3.18%	206,044 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $563,695 - $671,130	5,282 Added 2.72%	199,688 $23.9 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $338,486 - $396,525	3,678 Added 1.93%	194,406 $20.6 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $770,860 - $1.02 Million	10,171 Added 5.63%	190,728 $18.6 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $267,268 - $349,754	3,689 Added 2.09%	180,557 $16.9 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $147,272 - $196,400	-1,849 Reduced 1.03%	176,868 $15.1 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $15.4 Million - $17.7 Million	178,717 New	178,717 $17.1 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $9.36 Million - $14.3 Million	-110,040 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $8.27 Million - $12.5 Million	110,040 New	110,040 $9.52 Million

Others Institutions Holding NBIX

# of Institutions

655

Shares Held

96.6M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.6B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.

Account

Hood River Capital Management LLC Neurocrine Biosciences Inc Transaction History